NewTimeSpace News: 51WORLD (06651.HK) announced on 12 July that it has entered into a strategic cooperation in space-air domain with Huantian Wisdom. The two parties will jointly customise ECS-1 “Earth Clone Star”, the world’s first commercial remote sensing satellite dedicated to Physical AI training and simulation applications. Equipped with a 0.5m GSD optical payload, ECS-1 enables high-precision DSM & DEM generation in a single pass and cuts data acquisition costs by roughly 90%. The satellite has entered scheme review and tendering phase, targeting launch and constellation deployment by end-2027. A SAR satellite ECS-2 is also planned to support all-time, all-weather collaborative observation.
By the close of trading on Jul 10, 2026, ILUVATAR COREX(09903.HK) saw a loss of 18.68% in its share price, closing at HKD 482.2. During the session, it reached an intraday high of HKD 585.5 and touched an intraday low of HKD 476.6.
MIDEA GROUP(00300.HK) will spend CNY 108.05 million to repurchase 1.37 million shares on Jul 10, 2026 .
July 10, 2026, BLUE RIVER HLDG(00498.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 35.02 million, decreased by 10.23% YoY
NewTimeSpace News: CITIC SEC (06030.HK) announced on 10 July that it expects profit attributable to owners of the parent for the first half of 2026 to reach RMB23.343 billion, representing a year-on-year increase of 69.59% against restated figure of RMB13.764 billion for the same period last year. Profit attributable to owners of the parent excluding non-recurring items is projected at RMB23.610 billion, rising 73.40% versus restated RMB13.616 billion a year earlier. The upbeat performance is driven by buoyant capital market conditions and robust growth across business lines. The preliminary figures remain unaudited.
NewTimeSpace News: By the close of trading on Jul 10, 2026, KNOWLEDGE ATLAS(02513.HK) saw a loss of 19.29% in its share price, closing at HKD 1640. During the session, it reached an intraday high of HKD 1999 and touched an intraday low of HKD 1597.
NewTimeSpace News: By the close of trading on Jul 10, 2026, MINIMAX-W(00100.HK) saw a loss of 9.68% in its share price, closing at HKD 268.6. During the session, it reached an intraday high of HKD 291.6 and touched an intraday low of HKD 248.4.
NewTimeSpace News: Mongolia Energy announced on 10 July that Xinjiang Mengke, its indirect wholly-owned subsidiary, entered into a construction contract with the contractor to build a production command center at the Xinjiang coal washing plant, with a total consideration of RMB 6.529999 million (approximately HK$7.5095 million).
NewTimeSpace News: Xunce Technology announced on 10 July that the Company has submitted an application to the Hong Kong Stock Exchange for the listing and trading approval of US dollar-settled zero-coupon convertible bonds worth RMB 1.36 billion. The approval is expected to take effect on or around 13 July.
NewTimeSpace News: TAN CHONG INT'L (00693.HK) announced on 10 July that the Group expects to record an unaudited unrealised investment loss of approximately HK$512 million for the six months ended 30 June 2026, compared with an unrealised loss of HK$37 million in the same period last year. The loss arises from mark-to-market fluctuations of listed investments. Being unrealised, it will be recognised in other comprehensive income and will not flow through the consolidated statement of profit or loss. The figures are subject to further adjustments and the interim results will be published by end-August 2026.
NewTimeSpace News: CHINA LIFE INSURANCEannounced on 10 July that the Company intends to enter into a partnership agreement with CHINA LIFE INSURANCEIndustrial Investment before 31 December 2026 as a limited partner to set up a partnership enterprise. The total subscribed capital contribution of all partners will be RMB 5 billion, of which CHINA LIFE INSURANCEwill subscribe RMB 4.999 billion.
NewTimeSpace News: SBP GROUP (01177.HK) announced on 10 July that the New Drug Application (NDA) for TQB3454 Tablets, an in-house developed Category 1 innovative IDH1 inhibitor, has been accepted by CDE under NMPA for the treatment of advanced biliary tract cancer harbouring IDH1 mutations. The candidate obtained Breakthrough Therapy Designation in April 2023 and was included under Priority Review in May 2026. Its Phase III trial delivered significant improvements in PFS and OS, marking globally the second and domestically the first positive Phase III study for an IDH1 inhibitor in biliary tract cancer. No targeted therapy of the same target has yet been approved in China.
NewTimeSpace News: Pizu Groupannounced on 10 July that Mr. Hu Jingqiang resigned as Independent Non-executive Director and member of the Audit Committee, Remuneration Committee and Nomination Committee. Dr. Wei Lai has been appointed as Independent Non-executive Director and member of all the aforesaid committees.
NewTimeSpace News: DUFU LIQUOR GP (00986.HK) announced on 10 July that Mr Li Jingfu has been appointed CEO of the Company’s subsidiary with effect from 10 July 2026. He will conduct feasibility studies on the proposed AI digital human and internet marketing business, integration with the Group’s existing operations and business development roadmap, and formulate detailed plans. Mr Li currently serves as Co-founder and CEO of Ningbo Yunman Innovation Digital Technology. The Group intends to leverage his expertise to develop new business divisions and evolve into a professional service provider in AI intelligence sector.
NewTimeSpace News: SSY GROUP (02005.HK) announced on 10 July that Propylthiouracil Tablets (50mg) and Calcium Gluconate and Sodium Chloride Injection have secured drug registration approvals issued by NMPA, both deemed to have passed consistency evaluation. Propylthiouracil Tablets are the third domestically approved product of this kind, indicated for hyperthyroidism. The injection is used for acute hypocalcaemia, magnesium poisoning and fluoride poisoning.
NewTimeSpace News: XIWANG PROPERTY (02088.HK) announced on 10 July that Mr Wang An, Independent Non-executive Director, has resigned on account of advanced age and is no longer fit to discharge his director duties. Following the resignation, the number of independent non-executive directors and composition of Audit Committee and Remuneration Committee fail to comply with the Listing Rules. The Company will identify suitable candidates within three months. Mr Wang confirmed no disagreement with the Board. The Company’s shares will remain suspended.
